We read with great interest the article entitled "P-wave and QT dispersion in patients with conversion disorder" by Izci et al 1 in Therapeutics and Clinical Risk Management. In this well designed research, Izci et al studied QT dispersion (QTd) and P-wave dispersion (Pd) in patients with conversion disorder (CD). In conclusion, they reported that corrected QT (QTc) and QTd values were significantly altered in patients with CD when compared to healthy controls, but that there was no significant difference in terms of Pd.
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It has been postulated that the relationship between somatoform disorders and CD is related to altered autonomic functions. 2 These changes may affect the refractory period and conduction velocity of the heart. In line with these assumptions, heterogeneity in the duration of the ventricular repolarization phase leading to arrhythmias may also be seen in patients with CD. As in this study, QTd is the most frequently used parameter to detect ventricular inhomogeneity. However, reproducibility of QT interval measurements is low in both manual and automatic measurements and interobserver and intraobserver variability of QTd is very high. 3, 4 Quantifying the inhomogeneity of the myocardium, transmural dispersion of repolarization (TDR) has also been used since the beginning of the 2000s in addition to QTd. 5 There are three types of myocyte, ie, endocardial, epicardial, and midmyocardial M cells, each having different electrophysiological properties in the ventricular myocardium. Midmyocardial M cells have typically the longest repolarization phase. The repolarization phase of the midmyocardial M cells continues until the end of the T-wave. However, the repolarization phase of the epicardial cells ends at the peak of the T-wave. The time between the peak and end of the T-wave is known as the Tp-e interval, and is an index of the TDR. 5 In addition, the Tp-e/QT ratio has also been used as an electrical dispersion index for the myocardium, showing arrhythmic risk. The role of the TDR in evaluation of arrhythmic risk has been demonstrated in coronary artery disease and in the Brugada, short QT, and long QT syndromes. Previously, we showed that the Tp-e interval was increased in patients with obstructive sleep apnea. 6 On the other hand, the basic electrophysiological characteristics of the atrium that predispose to atrial arrhythmias are prolongation of intra-atrial and interatrial conduction times and heterogeneous propagation of sinus impulses. Pd is an accepted marker of atrial depolarization heterogeneity and the altered propagation of sinus 
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Tokatli et al impulses found to be associated with increased risk of atrial fibrillation. Although prolonged Pd values were found to be correlated with atrial fibrillation, it is controversial whether Pd is related to heterogeneity of atrial conduction or to other factors. Furthermore, reproducibility of P-wave measurements is low in both manual and automatic measurements and interobserver and intraobserver variability is very high. Atrial electromechanical coupling (AEC) can be assessed by electrocardiography-integrated tissue Doppler imaging and provides a means to determine the atrial mechanical and electrical event. Analysis of AEC by tissue Doppler imaging allows precise analysis of AEC between different regions. Moreover, measurement of AEC may suggest an inhomogeneous propagation of sinus impulses in different cardiac sites. Autonomic dysregulation and altered sympathovagal balance, as in somatoform disorders, may account for heterogeneity in atrial conduction properties. Measurement of AEC has been done in patients with psoriasis, ankylosing spondylitis, hyperthyroidism, end-stage renal disease, and hypertension. [7] [8] [9] Regarding these observations, autonomic imbalance may cause atrial depolarization and sinus impulse propagation abnormalities leading to altered AEC.
Our opinion is that, if AEC intervals had been measured in this study, they may have been found to be altered in patients with CD. Further, regarding the forementioned observations, if Izci et al had measured the Tp-e interval and Tp-e/QT ratio in their study, they might have found an increased TDR in their patients with CD. Considering all the data about Pd, AEC, QTd, and TDR, their study might have revealed the effects of CD on electrical heterogeneity of the myocardium more completely in many respects. 
Dear editor
We would like to thank Tokatli et al for their interest in our recent article in Therapeutics and Clinical Risk Management. 1 We are very glad to be given the opportunity to answer their letter.
QTd and Pd are considered to be indicators of cardiac arrhythmias and have been investigated in many psychiatric disorders. In the literature, there are many studies examining the relationship between anxiety disorders and P-wave dispersion (Pd), 2 which is considered to be an indirect indicator of atrial fibrillation, and QT dispersion (QTd), 3 which is considered to be an indirect indicator of ventricular arrhythmia. [4] [5] [6] As in anxiety disorders, heart rhythm disturbances have been observed in patients with somatoform disorders, and a relationship between heart rate and psychiatric conditions is thought to exist. 7, 8 Pd is considered to be a sensitive and specific indicator of atrial fibrillation in various clinical conditions. 9 Changes in cardiac atrial conduction are found to be associated with systemic autonomic symptoms observed during autonomic anxiety periods. In a study of healthy controls and 40 patients with panic disorder who experienced intense somatic symptoms, Pd was found to be prolonged in patients with panic disorder. 10 In another study examining the relationship between the presence of arrhythmia in anxiety disorders and Pd, state anxiety was found to influence Pd more than trait anxiety. 11 A study of 30 patients with hypochondriasis (a type of somatoform disorder) and 30 healthy controls revealed that Pd durations, which are considered to be associated with anxiety, were significantly higher in the patient group. 12 QTd was found to be significantly higher in patients with anxiety disorders, such as panic disorder and social phobia, than in controls, and this finding was thought to be associated with prolonged anxiety. 5, 6 Some studies have proposed that measured anxiety levels could be an indicator of prolonged QTd. 13 QTd was found to be higher in patients with higher levels of anxiety.
14 Also, in our study of patients with conversion disorder, which is a type of somatoform disorder, QTd was prolonged in the patient group and we mentioned that this group of patients might be at risk of ventricular arrhythmia. 1 Recently, atrial electromechanical coupling (AEC) and transmural dispersion of repolarization (TDR) have been used to determine the risk of cardiac arrhythmia as well as Pd and QTd. 15, 16 However, as far as we know, no study has investigated the risk of cardiac arrhythmia using these parameters in psychiatric disorders such as conversion disorder. According to our study findings, there was no significant difference in terms of Pd between the patient and control groups; however, reviewing possible changes in atrial conduction using AEC may be useful. As Tokatli et al have mentioned, investigating the risk of cardiac arrhythmia using AEC and TDR in patients who have conversion disorder and significant somatization and anxiety symptoms and confirming these findings with further studies may lead to important contributions to the literature.
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